CEO & Managing Director
Cellmid Limited, Sydney Australia
Maria Halasz has been involved with biotechnology companies for over 22 years; initially working in executive positions in biotechnology firms, then managing investment funds and later holding senior positions in corporate finance specialising in life sciences.
Since taking over as Chief Executive and Managing Director of Cellmid Maria has led the restructure of the business, the acquisition of the midkine and Advangen intellectual property portfolios and the recapitalisation of the company. An accomplished public company CEO with international experience Maria has executed transactions in the US, China, Europe, Japan and the UK.
Maria is a graduate of the University of Western Australia (B.Sc., MBA) and the Australian Institute of Company Directors. She has board experience in public and private companies, and has acted on advisory boards of non-profit organisations.